Ocugen, Inc. (OCGN)
1.315
-0.02
(-1.13%)
USD |
NASDAQ |
Sep 01, 12:52
Ocugen Cash and Short Term Investments (Quarterly) : 100.05M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 100.05M |
| March 31, 2026 | 31.86M |
| December 31, 2025 | 18.57M |
| September 30, 2025 | 32.56M |
| June 30, 2025 | 27.01M |
| March 31, 2025 | 37.80M |
| December 31, 2024 | 58.51M |
| September 30, 2024 | 38.70M |
| June 30, 2024 | 15.70M |
| March 31, 2024 | 26.38M |
| December 31, 2023 | 39.46M |
| September 30, 2023 | 53.48M |
| June 30, 2023 | 70.58M |
| March 31, 2023 | 76.72M |
| December 31, 2022 | 90.93M |
| September 30, 2022 | 101.60M |
| June 30, 2022 | 115.00M |
| March 31, 2022 | 129.77M |
| December 31, 2021 | 94.96M |
| September 30, 2021 | 107.35M |
| June 30, 2021 | 115.64M |
| March 31, 2021 | 44.79M |
| December 31, 2020 | 24.04M |
| September 30, 2020 | 19.11M |
| June 30, 2020 | 14.97M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.193M |
| December 31, 2019 | 7.444M |
| September 30, 2019 | 15.30M |
| June 30, 2019 | 2.786M |
| March 31, 2019 | 7.376M |
| December 31, 2018 | 1.628M |
| September 30, 2018 | 5.192M |
| June 30, 2018 | 8.772M |
| March 31, 2018 | 15.51M |
| December 31, 2017 | 7.981M |
| September 30, 2017 | 12.62M |
| June 30, 2017 | 18.54M |
| March 31, 2017 | 24.37M |
| December 31, 2016 | 31.91M |
| September 30, 2016 | 37.99M |
| June 30, 2016 | 15.93M |
| March 31, 2016 | 22.90M |
| December 31, 2015 | 30.92M |
| September 30, 2015 | 37.72M |
| June 30, 2015 | 45.22M |
| March 31, 2015 | 53.18M |
| December 31, 2014 | 58.06M |
| September 30, 2014 | 3.258M |
| June 30, 2014 | 7.776M |
| March 31, 2014 | 3.36M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Biogen, Inc. | 1.285B |
| Gilead Sciences, Inc. | 4.882B |
| MannKind Corp. | 111.13M |
| Vertex Pharmaceuticals, Inc. | 7.863B |